Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting

The present data article aims to describe the input parameters for a Markov model assessing the cost-effectiveness of four treatment sequences for patients with HER-2 positive metastatic breast cancer. The model input parameters include costs for physician visits, drugs, adverse event management, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaby, Vakaramoko, Wang, Ching-Yu, Alqhtani, Hussain, van Boemmel-Wegmann, Sascha, Ali, Askal Ayalew, Balkrishnan, Rajesh, Ko, Yu, Palacio, Sofia, de Lima Lopes, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Economics, Econometrics and Finance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011026/
https://www.ncbi.nlm.nih.gov/pubmed/32071975
http://dx.doi.org/10.1016/j.dib.2020.105194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011026/
https://www.ncbi.nlm.nih.gov/pubmed/32071975
http://dx.doi.org/10.1016/j.dib.2020.105194

Ejemplares similares